Veru (VERU) filed separate registration statements late Tuesday with the US Securities and Exchange Commission for the sale of up to $200 million of its securities from time to time and 23.8 million shares of its common stock through the issuance of warrants.

The securities cover common and preferred stocks, debt securities, warrants, purchase contracts, rights and units, the company said.

Veru said it plans to use proceeds from the mixed-shelf and common stock offerings for general corporate purposes, including research and development and clinical trials.